Pricing Log in Create free account
Tuesday 20 October 2026 Export INCY’s income statement to Excel — free account

Incyte Corporation

INCY Healthcare Biotechnology

Incyte Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 21.2% from fiscal 2024. In the quarter to June 2026, revenue grew 37.7%, EPS grew 39.7%, free cash flow grew 1,829.5% and total debt fell 10.5%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years.

115.09 1.84 +1.62%
Market cap
$23.0B
P/E
13.9×
Fwd P/E
58.4×
Dividend yield
—
F-score
9/9
Altman Z
8.57
Beneish M
−2.43
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Incyte Corporation (INCY) Book value per share

Alert me on Book value per share

Incyte Corporation's book value per share at the end of fiscal 2025 was 26.5×, up 59.0% from 16.6× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 31.7×. Over the past ten years it has ranged from 1.0× (fiscal 2015) to 26.5× (fiscal 2025) — the current reading is the highest in ten years. Incyte Corporation ranks 21st of 635 Biotechnology companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 26.5× 59.03%
FY2024 16.6× (28.27%)
FY2023 23.2× 17.89%
FY2022 19.7× 15.10%
FY2021 17.1× 42.83%
FY2020 12.0× (0.96%)
FY2019 12.1× 33.33%
FY2018 9.1× 13.77%
FY2017 8.0× 256.99%
FY2016 2.2× 134.28%

Quarterly newest first

Period Book value per share Change
Jun 2026 31.7× 12.25%
Mar 2026 28.2× 6.55%
Dec 2025 26.5× 11.37%
Sep 2025 23.8× 10.56%
42 more quarters

Against its own ten years

Low 1.0× High 26.5×
Ten-year median 12.1×
Current reading's percentile 100

Book value per share against peers

Company Book value per share
BNTX BioNTech SE Sponsored ADR compare 81.5×
INCY Incyte Corporation 31.7×
ASND Ascendis Pharma A/S compare 26.0×
RPRX Royalty Pharma PLC compare 22.0×
ALNY Alnylam Pharmaceuticals, Inc. compare 10.1×
GMAB Genmab A/S Sponsored ADR compare 9.7×
EXEL Exelixis, Inc. compare 7.4×
ROIV Roivant Sciences Ltd. compare 6.8×
INSM Insmed, Inc. compare 3.5×

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on INCY